story of the week
Bipolar Androgen Therapy vs Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
TRANSFORMER: A Randomized Phase II Study Comparing Bipolar Androgen Therapy Versus Enzalutamide in Asymptomatic Men With Castration-Resistant Metastatic Prostate Cancer
J. Clin. Oncol 2021 Feb 22;[EPub Ahead of Print], SR Denmeade, H Wang, N Agarwal, DC Smith, MT Schweizer, MN Stein, V Assikis, PW Twardowski, TW Flaig, RZ Szmulewitz, JM Holzbeierlein, RJ Hauke, G Sonpavde, JA Garcia, A Hussain, O Sartor, S Mao, H Cao, W Fu, T Wang, R Abdallah, SJ Lim, V Bolejack, CJ Paller, MA Carducci, MC Markowski, MA Eisenberger, ES AntonarakisFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Advanced Prostate Cancer Center of Excellence
Visit our Advanced Prostate Cancer Center of Excellence for additional, in-depth coverage.